文献速递糖尿病

芬兰1型糖尿病中ST段抬高与非ST段抬高心肌梗死的发病率模式与风险特征比较:全国队列研究

Comparison of incidence patterns and risk profiles of ST-elevation and non-ST-elevation myocardial infarction in type 1 diabetes in Finland: a nationwide cohort study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2026-03-20

该研究基于FinnDiane队列纳入4215名无心肌梗死或血运重建史的1型糖尿病成人,随访1997–2017年,验证449例首发心肌梗死(STEMI 84例,NSTEMI 297例)。STEMI与NSTEMI的风险特征不同。

要点

  • 1型糖尿病中NSTEMI累积发病率高于STEMI,且随年龄增长更明显。
  • NSTEMI风险与 older onset age、LDL-C升高、HDL-C降低、严重视网膜病变、严重白蛋白尿及肾脏替代治疗相关。
  • STEMI风险与中度及重度eGFR下降相关,而NSTEMI无此关联。

核心结论

  • STEMI和NSTEMI在1型糖尿病中表现出随年龄和心梗发生年份不同的发病率模式。
  • STEMI与NSTEMI的风险特征存在差异,提示心梗风险评估涉及多种风险因素的复杂交互。

研究设计与样本

  • 前瞻性多中心队列FinnDiane研究,纳入4215名无心肌梗死或冠状动脉血运重建史的1型糖尿病成人。
  • 采用Fine and Gray竞争风险分析计算标准化年龄、性别及并发症特异发病率,用Cox回归和Fine and Gray模型评估风险特征。

主要发现

  • 共验证449例首发临床记录心肌梗死,其中STEMI 84例(19%),NSTEMI 297例(66%)。
  • 发病率无性别差异,但随年龄增长而增加,尤其NSTEMI。
  • 与1997–2002年参照期相比,STEMI发病率下降,而NSTEMI发病率在初期下降后于随访期间上升。
  • older diabetes onset age、LDL胆固醇升高、HDL胆固醇降低、严重糖尿病视网膜病变、严重白蛋白尿及肾脏替代治疗与NSTEMI风险增加相关,但与STEMI无关;中度及重度eGFR下降与STEMI风险增加相关,但与NSTEMI无关;糖尿病病程更长、HbA1c更高及当前吸烟与两种心梗亚型风险增加均相关。

临床怎么用

  • 在1型糖尿病中评估心梗风险时,应区分STEMI与NSTEMI,并关注不同的风险特征组合。
  • 对具有 older onset age、血脂异常、严重视网膜病变、严重白蛋白尿或肾脏替代治疗者,应加强NSTEMI风险监测。
  • 对eGFR中度至重度下降者,应关注STEMI风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence and risk profiles of ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) are understudied in type 1 diabetes. We aimed to study the similarities and differences in the incidence and risk profiles of myocardial infarction subtypes in people with type 1 diabetes. METHODS: This prospective, multicentre cohort, the FinnDiane Study includes adults with type 1 diabetes, with no previous history of myocardial infarction or coronary revascularisation. Standardised age-specific, sex-specific, and complication-specific incidence rates of myocardial infarction subtypes STEMI and NSTEMI were calculated in Fine and Gray competing risk analyses. The risk profiles were assessed with Cox regression and Fine and Gray competing risk models. FINDINGS: 4215 adults with type 1 diabetes who were enrolled in the Finnish Diabetic Nephropathy Study between Nov 21, 1997, and Dec 31, 2012, were included in this study. We verified 449 first-ever clinically recorded myocardial infarctions, including 84 (19%) STEMIs and 297 (66%) NSTEMIs, from medical records and death certificates between 1997 and 2017. The 20-year cumulative incidence was 15·4% (95% CI 12·0-19·1) for all myocardial infarctions, 2·4% (1·9-2·9) for STEMI, and 10·9% (7·8-14·6) for NSTEMI, with no differences by sex, but increasing with older age, particularly for NSTEMI. Compared with the reference period between 1997 and 2002, the incidence of STEMI decreased, while after an initial decline, NSTEMI incidence increased during follow-up. Older diabetes onset age, increased LDL cholesterol, reduced HDL cholesterol, severe diabetic retinopathy, severe albuminuria, and kidney replacement therapy were associated with increased risk of NSTEMI, but not of STEMI. Conversely, moderately and severely decreased eGFR were associated with increased risk of STEMI, but not of NSTEMI. Longer duration of diabetes, higher HbA1c, and current smoking were associated with increased risk of both myocardial infarction subtypes. INTERPRETATION: We report that STEMI and NSTEMI exhibit different incidence patterns depending on age and year of myocardial infarction. STEMI and NSTEMI also differed regarding risk profiles, demonstrating that myocardial infarction risk assessment involves a complex interplay between multiple risk factors in type 1 diabetes. FUNDING: Folkhälsan Research Foundation, Wilhelm and Else Stockmann Foundation, Liv och Hälsa Society, Sigrid Jusélius Foundation, State funding for university-level health research by Helsinki University Hospital, Medical Society of Finland, Diabetes Research Foundation, and Finnish Foundation for Cardiovascular Research.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Smidtslund P, Harjutsalo V, Thorn V, et al. Comparison of incidence patterns and risk profiles of ST-elevation and non-ST-elevation myocardial infarction in type 1 diabetes in Finland: a nationwide cohort study. Lancet Diabetes Endocrinol. 2026. PMID: 41871591. doi:10.1016/S2213-8587(25)00368-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。